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Clinical Record
Development of cavernous haemangioma following radical
chemo-radiotherapy for nasopharyngeal carcinoma
J R ELLENBOGEN, S M JOSHI, N KITCHEN
Abstract
Objective: We report an adult case of nasopharyngeal carcinoma treated with radical chemo-radiotherapy, with
subsequent development of a histologically proved temporal cavernous haemangioma within the radiation field.
Method: Case report and review of the current literature concerning radiation-induced, secondary,
space-occupying lesions.
Conclusion: The increasing role of radiotherapy in nasopharyngeal carcinoma treatment, together with
improved patient survival, is likely to lead to radiation-induced, secondary, space-occupying lesions being
encountered more frequently. We emphasise the need to be vigilant for this important but relatively rare
complication, which has significant associated morbidity.
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Introduction
Although nasopharyngeal carcinoma (NPC) is a rare tumour,
it accounts formore than 95percent of nasopharyngealmalig-
nancies in adults and 20 to 35 per cent of those in children.1 It
is a highly morbid disease with a poor survival outcome. The
use of radiotherapy to treat head and neck tumours is increas-
ing, either as primary or adjunctive therapy. The risk of
radiation-induced, secondary, space-occupying lesions is a
growing topic of investigation and concern.
We report an adult case of NPC treated with radical
chemo-radiotherapy, with subsequent development of a
histologically proved cavernous haemangioma within the
radiation field. Such a case has not previously been
reported in the literature. The increasing role of radiother-
apy in NPC treatment, and improved patient survival rates,
are likely to lead to these secondary tumours been encoun-
tered more frequently. We also review the current litera-
ture on this condition.
Case report
A 57-year-old woman presented in April 2000 with pain
and deafness in the left ear and left facial numbness.
Examination under anaesthesia and imaging at that stage
showed an extensive nasopharyngeal carcinoma (NPC)
eroding through the pterygoid plate and invading the sphe-
noid and the posterior ethmoid sinus, with a lymph node
present in the retropharynx. Biopsies confirmed an undiffer-
entiated carcinoma of nasopharyngeal type, and further
magnetic resonance imaging (MRI) identified extensive
disease throughout the sphenoid, extending to the pituitary
and middle cranial fossa. The disease did however appear
to be extradural. Unusually for such an extensive primary
tumour, the patient had no cervical lymphadenopathy.
Thepatientwent on to receive radical chemo-radiotherapy.
Following her treatment, further biopsies taken in June 2000
confirmed that she had residual disease within the
nasopharynx.
The patient underwent further full adjuvant chemother-
apy treatment with cisplatin and 5-fluorouracil. At this
point, residual tumour was resected and gold grains were
implanted at the primary site.
Following this treatment, the patient remained disease-
free. However, she suffered sequelae as a consequence of
her radical treatment, namely, pain in the trigeminal
nerve distribution on the left side, deafness in the left ear
and loss of vision in the left eye.
In 2001, computed tomography scanning identified an
area in the left temporal lobe suggestive of necrosis second-
ary to radiotherapy, and MRI scans taken between May
2006 and early 2007 showed that this area had developed
into a large, cystic mass (Figure 1). In June 2006, a positron
emission tomography scan, performed to exclude recur-
rence, showed no uptake within this region, despite
normal uptake elsewhere in the brain.
In April 2007, the patient was admitted to The National
Hospital for Neurology andNeurosurgery for a left temporal
craniotomy for resection of the cystic tumour. At that time,
she complained of her continued left facial pain, unsteady
gait and decreased memory. Intra-operatively, a large,
cystic lesion in the left temporal lobe with what appeared
to be a cavernous haemangioma at the base was excised.
Histological analysis confirmed a cavernous haemangioma
and gliotic brain tissue.
After surgery, the patient’s condition improved both
physically and emotionally, and her pain was less intrusive.
Discussion
The typical radiation field for nasopharyngeal carcinoma
(NPC) treatment encompasses the adjacent skull base,
sphenoid sinus, middle cranial fossa and the soft tissue
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juxtaposed to the nasopharynx.1 Patients undergoing a full
course of radiotherapy for NPC will receive a dose of 66–
70 Gy to this large area. This is above the 55 Gy at which
the dose–response relationship between radiation dose
and secondary induced tumour risk has been demonstrated
to increase.2
The common complications of radiotherapy to the head
and neck have been well documented. Some rarer compli-
cations which have been reported after NPC radiotherapy,
with potentially serious consequences, include temporal
bone necrosis and abscess formation,3 temporal bone
tumours,4 sarcomas,2 and, in the current case, cavernous
haemangioma. The five-year incidence of secondary
primary tumours following radiotherapy for NPC has
been shown to be 5.8 per cent.5
Cavernous haemangiomas are vascular malformations
composed of dilated, thin-walled capillaries consisting of
a single layer of endothelium and differing quantities of
subendothelial fibrous stroma, with absence of smooth
muscle and elastic fibres. These sinusoidal-type vessels
are immediately in apposition to each other, without any
recognisable intervening neural parenchyma. They can
vary in size from punctate to several centimetres across,
and can occur anywhere in the intracranial parenchyma,
as well as in the spinal cord and on cranial and spinal
nerve roots.
Although a benign vascular developmental malfor-
mation, cavernous haemangiomas have been identified to
occur as a result of radiation therapy. Radiation-induced,
de novo formation of cavernous haemangiomas is rarely
reported, but recently has been observed with increasing
frequency. The majority of such lesions have been observed
in the male paediatric population.6 One study demon-
strated a sixfold prevalence rate of cavernous haemangio-
mas in children aged between two to 11 years at the time
of radiotherapy, compared with that cited in the literature
for this population. The latency interval between radiother-
apy and cavernous haemangioma development has been
found to be three to 102 months (median 37 months).7
Cavernous haemangiomas have also been reported to
occur in the radiation field of children, seven to 19 years
after radiation treatment for paediatric brain tumours
(medulloblastomas, ependymoma and midbrain astrocy-
toma).8 A review of de novo cavernous malformations of
the central nervous system arising after radiotherapy
identified a mean latency period until lesion detection of
8.9 years after a mean radiation dose of 60.45 Gy, across
all primary tumours in adults and children.6 Radiation-
induced vascular malformations have been found to occur
in a noticeably shorter time interval, compared with other
benign, radiation-induced tumours.9
Although rare, these secondary tumours are associated
with significant morbidity. Patients with cavernous hae-
mangiomas may remain asymptomatic and unaware of
their vascular lesion; however, they may alternatively
present with symptoms of intracranial haemorrhage, sei-
zures, progressive or transient neurological deficits, and
headaches. The risk of haemorrhage has been suggested
to be between 0.25 and 0.7 per cent per lesion per year.10,11
The pathophysiologicalmechanisms of radiation-induced
cavernous haemangioma formation are not clearly under-
stood. Various authors have suggested mechanisms predis-
posing to cavernous malformation secondary to radiation,
including: genetic mutation; growth factor up-regulation;
radiation-induced vessel wall necrosis; and vessel wall
changes including cell swelling, hyalinisation, fibrosis and
mineralisation.6,12 However, such theories are yet to be
substantiated.
. The increasing role of radiotherapy in
nasopharyngeal carcinoma (NPC) treatment,
together with improved patient survival, is likely to
lead to radiation-induced, secondary,
space-occupying lesions being encountered more
frequently
. This report describes an adult case of NPC treated
with radical chemo-radiotherapy, with subsequent
development of a cavernous haemangioma within
the radiation field
. The authors emphasise the need to be vigilant for
this important but relatively rare complication,
which has significant associated morbidity
It is debatable whether radiation-induced cavernous hae-
mangiomas develop from previously overlooked precursors
or are, in fact, de novo malformations. The fact that they
occur within the radiation field, as in our case, supports
the theory that they arise de novo.2 Other supporting evi-
dence lies in the fact that, in children less than 10 years of
age, the length of the latency period between radiation
and cavernous haemangioma formation has been shown to
be dependent on the total radiation dose.13 In children,
the higher the radiation dose, over 30 Gy, the shorter the
latency period; in adults, cavernous haemangiomas have
been shown to develop only above a 30 Gy threshold.13 It
is unclear why cavernous malformations occur more fre-
quently in children than adults after radiotherapy. The
immature brain may be more sensitive to radiotherapy-
induced changes than the mature brain.14
Conclusion
We report an adult case of nasopharyngeal carcinoma
treated with radical chemo-radiotherapy, with subsequent
development of a histologically proved temporal cavernous
haemangioma within the radiation field. It is likely that,
FIG. 1
Axial, T2-weighted magnetic resonance imaging brain scan,
demonstrating the lesion.
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with the increasing use of radiotherapy and the associated
increase in life expectancy, radiation-induced secondary
tumours will become more commonplace. It is vital that
clinicians remain vigilant for this important but relatively
rare complication, as early detection can enable timely
intervention and a reduction in potentially significant
morbidity.
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